📬 Stay connected after #ELRIGDD26. Visit Stand J01 to sign up for our newsletter and receive updates on ECACC products, resources, and events. https://bit.ly/4tUSrfd
@elrig.org #ECACC #DrugDiscovery #LifeSciences

📬 Stay connected after #ELRIGDD26. Visit Stand J01 to sign up for our newsletter and receive updates on ECACC products, resources, and events. https://bit.ly/4tUSrfd
@elrig.org #ECACC #DrugDiscovery #LifeSciences
🧬 Discover ECACC's authenticated cancer cell lines at #ELRIGDD26. Visit Stand J01 to learn how they support oncology and drug discovery research.
@elrig.org #ECACC #DrugDiscovery #UKHSA
🧫 Explore ECACC products and services at #ELRIGDD26. Visit Stand J01 to learn how authenticated cell culture resources can support your research.
@elrig.org #ECACC #DrugDiscovery #LifeSciences
👋 Day 1 of #ELRIGDD26. Visit Stand J01 to meet the Culture Collections team and discover resources that support drug discovery and life sciences research. @elrig.org
🔬 We're exhibiting at #ELRIGDD26 on 14-15 October. Visit the Culture Collections team at Stand J01 to discover how our biological resources support drug discovery and life sciences research. @elrig.org
Karpas 707 is a human multiple myeloma cell line that secretes λ light chain and carries the Philadelphia chromosome. It is a valuable model for studying plasma cell malignancies, chromosome abnormalities, and bone disease associated with myeloma. https://bit.ly/4z9jGpX #ECACC
DLRP 20082610: A metastatic squamous cell lung carcinoma cell line with multiple chromosomal abnormalities, supporting drug resistance, anticancer therapy, and cancer genetics research. Find out more: https://bit.ly/472razB #CellLinesInAction #ECACC #UKHSA
SK-N-BE(2) is a widely used neuroblastoma cell line with reported N-myc amplification, making it an important model for high-risk neuroblastoma, cancer genetics and oncogene regulation research. Find out more: https://bit.ly/4wkT2YK #CellLinesInAction #ECACC #UKHSA
A key tool in oral cancer research. Derived from a human tongue squamous cell carcinoma, this cell line is widely used to investigate cancer progression, apoptosis and treatment response. Find out more: https://bit.ly/4g8WtvA #CancerResearch #CellLinesInAction #UKHSA #ECACC
HOS R970-5 is a trusted osteogenic sarcoma model for studying bone cancer progression, viral replication, and drug resistance. Its high sensitivity to chemical and viral testing makes it a valuable platform for cancer research. https://bit.ly/4q3upy2 #CellLinesInAction #ECACC
U-2 OS is a bone sarcoma cell line widely used in bone biology, cancer, and arthritis research. Its epithelial-like morphology also makes it ideal for advanced cell imaging applications. View profile: https://bit.ly/4hstEfT
#CancerResearch #CellLinesInAction #BoneCancer #ECACC
We have a job vacancy for an ECACC Operations Lead at UKHSA to lead manufacturing, quality control, and human genetic services operations while ensuring regulatory compliance and managing operational teams. Learn more and apply today https://bit.ly/4gTPeYA #UKHSA #ECACC #Vacancy
We have a job vacancy for an ECACC Operations Lead at UKHSA to lead manufacturing, quality control, and human genetic services operations while ensuring regulatory compliance and managing operational teams. Learn more and apply today https://bit.ly/4gTPeYA #UKHSA #ECACC #Vacancy
SH-SY5Y is a neuroblastoma-derived cell line widely used in neurobiology research. Its ability to differentiate into neuron-like cells makes it a valuable model for studying neuronal function and disease. https://bit.ly/4q5xGNq #CellLinesInAction #CancerResearch #ECACC
PNT2 is a non-malignant prostate epithelial cell line widely used as a healthy control in prostate cancer research. It supports studies of cancer progression, cell mechanics, and tumour invasiveness. https://bit.ly/4c7QuWo #CancerResearch #ProstateCancer #ECACC
PANC-1 is a pancreatic ductal adenocarcinoma cell line used to study tumour biology, treatment responses, and targeted therapies. Its neuroendocrine features also make it valuable for investigating emerging therapeutic approaches. View profile: https://bit.ly/4fMIJHT
#ECACC